Cited by 188Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMedical Imaging Techniques and Applications

Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease

Open access
Mosconi, L., Mistur, R., Switalski, R., Brys, M., Glodzik, L., Rich, K., Pirraglia, E., Tsui, W. +2 more·2009·Neurology

Abstract

BACKGROUND: At cross-section, cognitively normal individuals (NL) with a maternal history of late-onset Alzheimer disease (AD) have reduced glucose metabolism (CMRglc) on FDG-PET in the same brain regions as patients with clinical AD as compared to those with a paternal and a negative family history (FH) of AD. This longitudinal FDG-PET study examines whether CMRglc reductions in NL subjects with a maternal history of AD are progressive. METHODS: Seventy-five 50- to 82-year-old NL received 2-year follow-up clinical, neuropsychological, and FDG-PET examinations. These included 37 subjects with negative family history of AD (FH-), 9 with paternal (FHp), and 20 with maternal AD (FHm). Two subjects had parents with postmortem confirmed AD. Statistical parametric mapping was used to compare CMRglc across FH groups at baseline, follow-up, and longitudinally. RESULTS: At both time points, the FH groups were comparable for demographic and neuropsychological characteristics. At baseline and at follow-up, FHm subjects showed CMRglc reductions in the parieto-temporal, posterior cingulate, and medial temporal cortices as compared to FH- and FHp (p < 0.001). Longitudinally, FHm had significant CMRglc declines in these regions, which were significantly greater than those in FH- and FHp (p < 0.05). CONCLUSIONS: A maternal history of Alzheimer disease (AD) predisposes normal individuals to progressive CMRglc reductions in AD-vulnerable brain regions, which may be related to a higher risk for developing AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000333247.51383.43

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Maternal inheritance appears to determine several AD endophenotypes.

    “Maternal inheritance appears to determine several AD endophenotypes.”
  • Cognitively intact children of AD mothers, relative to children of AD fathers, show greater age-associated brain atrophy, faster longitudinal brain atrophy, increased Aβ plaque deposition, elevated CSF oxidative stress markers, and AD-like CSF Aβ changes.

    “Subsequent studies found that the cognitively intact children of AD mothers, relative to the cognitively intact children of AD fathers, show greater degrees of age-associated brain atrophy, faster rates of longitudinal brain atrophy, increased Aβ plaque deposition, elevated cerebrospinal fluid (CSF) oxidative stress markers, and AD-like CSF Aβ changes [130-137].”
  • IN insulin may support impaired brain glucose turnover in patients with AD and at-risk individuals.

    “In addition to improvements in insulin signalling, IN insulin may support impaired brain glucose turnover in patients with AD and at-risk individuals.143,144”

    From Intranasal insulin (2021) · cites this paper as [144]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. Ehrenkrantz D, Silverman JM, Smith CJ, et al. Genetic epidemiological study of maternal and paternal transmis- sion of Alzheimer's disease. Am J Med Genet 1999;88: 378-382.
  2. de Leon MJ, Convit A, Wolf OT, et al. Prediction of cog- nitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission to- mography (FDG/PET). Proc Natl Acad Sci USA 2001;98: 10966-10971.
  3. George AE, de Leon MJ, Kalnin A, Rosner L, Goodgold A, Chase N. Leukoencephalopathy in normal and pathologic aging: 2. MRI and brain lucencies. Am J Neuroradiol 1986;7:567-570.
  4. Reivich M, Alavi A, Wolf A, et al. Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for [18F]fluorodeoxy- glucose and [11C]deoxyglucose. J Cereb Blood Flow Metab 1985;5:179-192.
  5. Mosconi L, Tsui WH, De Santi S, et al. Reduced hip- pocampal metabolism in mild cognitive impairment and Alzheimer's disease: automated FDG-PET image analysis. Neurol 2005;64:1860-1867.
  6. Mosconi L, Tsui WH, Pupi A, et al. (18)F-FDG PET database of longitudinally confirmed healthy elderly im- proves detection of MCI and AD. J Nucl Med 2007;48: 1129-1134.
  7. American Psychiatric Association. Diagnostic and Statisti- cal Manual of Mental Disorders (Fourth Edition). 4 ed. Washington, DC: American Psychiatric Association; 1994.

Cited by

Sorted by citations

Authors
Mosconi, L., Mistur, R., Switalski, R., Brys, M., Glodzik, L., Rich, K., Pirraglia, E., Tsui, W., De Santi, S., & de Leon, M. J.
Affiliations
  • Nathan Kline Institute for Psychiatric Research (US)
  • From New York University School of Medicine (L.M., R.M., R.S., M.B., L.G., K.R., E.P., W.T., S.D.S., M.J.d.L.), New York; and Nathan S. Kline Institute for Psychiatric Research (W.T., M.J.d.L.), Orangeburg, NY.
Venue
Neurology
Published
2009-02-10
Volume
72
Issue
6
Pages
513-520
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W1964043919
Cited by
188
References
36
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 12 · 2021: 8 · 2020: 8 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 7 · 2015: 11 · 2014: 15 · 2013: 18 · 2012: 21
FWCI
11.45
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Alzheimer's Association
  • National Institutes of Health (MO1RR0096, AG12101, AG08051)
  • National Institute on Aging (AG022374, R01AG022374, AG 12101, R01AG012101, P30AG008051, AG 08051, R01AG013616, AG 13616)
  • National Center for Research Resources (MO1-RR-0096, M01RR000096)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
Alzheimer's disease, family history (medicine), maternal history, brain glucose metabolism, FDG-PET, cognitively normal individuals, longitudinal decline, temporoparietal cortex, posterior cingulate cortex, medial temporal cortex, familial risk, neurodegeneration
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain, Female, Glucose, Heterozygote, Humans, Male, Middle Aged, Mothers, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review